ICL Group Q3 2024 Adj. EPS $0.11 Beats $0.08 Estimate, Sales $1.753B Miss $1.788B Estimate
ICL Group Q3 2024 Adj. EPS $0.11 Beats $0.08 Estimate, Sales $1.753B Miss $1.788B Estimate
以色列化學2024年第三季度調整每股收益爲0.11美元,超過了0.08美元的預期,銷售額爲17.53億美元,低於17.88億美元的預期
ICL Group (NYSE:ICL) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.08 by 37.5 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.753 billion which missed the analyst consensus estimate of $1.788 billion by 1.98 percent. This is a 5.85 percent decrease over sales of $1.862 billion the same period last year.
以色列化學(紐交所:ICL)報告每股盈利爲0.11美元,超出分析師共識預期的0.08美元,增幅達37.5%。與去年同期相比持平。公司報告季度銷售額爲17.53億美元,低於分析師共識預期的17.88億美元,下降1.98%。相比去年同期的18.62億美元,銷售額下降了5.85%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。